Tryptophan as a link between psychopathology and somatic states

Psychosomatic Medicine

Volumn 65, Issue 4, 2003, Pages 665-671

  Russo, Sascha ^a   Kema, Ido P ^a   Fokkema, M Rebecca ^a   Boon, Jim C ^a   Willemse, Pax H B ^a   De Vries, Elisabeth G E ^a   Den Boer, Johannes A ^a   Korf, Jakob ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Depression; Psychiatry; Review; Serotonin; Somatic; Tryptophan

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; 5 HYDROXYTRYPTOPHAN; ALPHA INTERFERON; BETA INTERFERON; KYNURENINE; SEROTONIN; TRYPTOPHAN; TRYPTOPHAN 2,3 DIOXYGENASE;

ANXIETY DISORDER; AUTISM; BRAIN; CATABOLISM; COMORBIDITY; COMPULSION; DATA BASE; DEPLETION; DEPRESSION; DIARRHEA; ENDOCRINE DISEASE; FEVER; GASTROINTESTINAL DISEASE; HUMAN; INFECTION; INFLAMMATION; IRRITABILITY; MALAISE; MEDICAL LITERATURE; MENTAL DISEASE; NAUSEA; PANIC; PREMENSTRUAL SYNDROME; PRIORITY JOURNAL; REVIEW; SEROTONIN METABOLISM; STRESS; SUICIDE; VOMITING;

ANIMALS; ANXIETY; BRAIN CHEMISTRY; DEPRESSION; DISEASE; ENDOCRINE SYSTEM DISEASES; FEMALE; GASTROINTESTINAL DISEASES; HUMANS; HYDROCORTISONE; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; INFECTION; INFLAMMATION; INTERFERONS; IRRITABLE MOOD; KYNURENINE; MALE; RATS; SEROTONIN; STRESS; TRYPTOPHAN; TRYPTOPHAN HYDROXYLASE; TRYPTOPHAN OXYGENASE;

EID: 0041843822     PISSN: 00333174     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.PSY.0000078188.74020.CC     Document Type: Review

References (82)

1. Sonino N, Fava GA, Raffi AR, Boscaro M, Fallo F. Clinical correlates of major depression in Cushing's disease. Psychopathology 1998;31:302-6.
2. Soderlin MK, Hakala M, Nieminen P. Anxiety and depression in a community-based rheumatoid arthritis population. Scand J Rheumatol 2000;29:177-83.
3. Lipsey JR, Robinson RG, Pearlson GD, Rao K, Price TR. Mood change following bilateral hemisphere brain injury. Br J Psychiatry 1983;143:266-73.
4. Fassbender K, Schmidt R, Mossner R, Kischka U, Kuhnen J, Schwartz A, Hennerici M. Mood disorders and dysfunction of the hypothalamic-pituitary-adrenal axis in multiple sclerosis: association with cerebral inflammation. Arch Neurol 1998;55:66-72,
5. Sandyk R. L-tryptophan in neuropsychiatric disorders: a review. Int J Neurosci 1992;67:127-144.
6. Young SN. The use of diet and dietary components in the study of factors controlling affect in humans: a review. J Psychiatry Neurosci 1993;18:235-44.
7. Coppen AJ, Doogan DP. Serotonin and its place in the pathogenesis of depression. J Clin Psychiatry 1988;49,4-11 (Suppl).
8. Eynard N, Flachaire E, Lestra C, Broyer M, Zaidan R, Claustrat B, Quincy C. Platelet serotonin content and free and total plasma tryptophan in healthy volunteers during 24 hours. Clin Chem 1993;39:2337-40.
9. Young SN, Ervin FR, Pihl RO, Finn P. Biochemical aspects of tryptophan depletion in primates. Psychopharmacology 1989;98:508-11.
10. Etienne P, Young SM, Sourkes TL. Inhibition by albumin of tryptophan uptake by rat brain. Nature 1976;262:144-5.
11. Yuwiler A, Oldendorf WH, Geller E, Braun L. Effect of albumin binding and amino acid competition on tryptophan uptake into brain. J Neurochem 1977;28:1015-23.
12. Pardridge WM, Fierer G. Transport of tryptophan into brain from the circulating, albumin-bound pool in rats and in rabbits. J Neurochem 1990;54:971-6.
13. Delgado PL, Charney DS, Price LH, Aghajanian GK, Landis H, Heninger GR. Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan. Arch Gen Psychiatry 1990;47:411-18.
14. Fadda F, Cocco F, Stancampiano R. A physiological method to selectively decrease brain serotonin release. Brain Res Protoc 2000;5:219-22.
15. Bender DA. Biochemistry of tryptophan in health and disease. Mol Aspects Med 1983;6:101-97.
16. Martin CL, Duclos M, Aguerre S, Mormede P, Manier G, Chaouloff F. Corticotropic and serotonergic responses to acute stress with/without prior exercise training in different rat strains. Acta Physiol Scand 2000;168:421-30.
17. Maes M, Jacobs MP, Suy E, Minner B, Leclercq C, Christiaens F, Raus J. Suppressant effects of dexamethasone on the availability of plasma L-tryptophan and tyrosine in healthy controls and in depressed patients. Acta Psychiatr Scand 1990;81:19-23.
18. Stark GR, Kerr IM, Williams BR, Silverman RH, Schreiber RD. How cells respond to interferons. Annu Rev Biochem 1998;67:227-64.
19. Thomas SR, Stocker R. Redox reactions related to indoleamine 2,3-dioxygenase and tryptophan metabolism along the kynurenine pathway. Redox Rep 1999;4:199-220.
20. Iwagaki H, Hizuta A, Uomoto M, Takeuchi Y, Saito S, Tanaka N. Cancer cachexia and depressive states: a neuro-endocrine-immunological disease? Acta Med Okayama 1997;5:233-6.
21. Sanni LA, Thomas SR, Tattam BN, Moore DE, Chaudhri G, Stocker R, Hunt NH. Dramatic changes in oxidative tryptophan metabolism along the kynurenine pathway in experimental cerebral and noncerebral malaria. Am J Pathol 1998;152:611-619.
22. Heyes MP, Saito K, Major EO, Milstien S, Markey SP, Vickers JH. A mechanism of quinolinic acid formation by brain in inflammatory neurological disease. Attenuation of synthesis from L-tryptophan by 6-chlorotryptophan and 4-chloro-3-hydroxyanthranilate. Brain 1993;116:1425-50.
23. Moroni F. Tryptophan metabolism and brain function: focus on kynurenine and other indole metabolites. Eur J Pharmacol 1999;375:87-100.
24. Stone TW. Inhibitors of the kynurenine pathway. Eur J Med Chem 2000;35:179-86.
25. 6. Br J Nutr 1999;81:7-20.
26. Fuchs D, Moller AA, Reibnegger G, Werner ER, Werner FG, Dierich MP, Wachter H. Increased endogenous interferon-gamma and neopterin correlate with increased degradation of tryptophan in human immunodeficiency virus type 1 infection. Immunol Lett 1991;28:207-11.
27. Reilly JG, McTavish SF, Young AH. Rapid depletion of plasma tryptophan: a review of studies and experimental methodology. J Psychopharmacol 1997;11:381-92.
28. Delgado PL, Moreno FA. Role of norepinephrine in depression. J Clin Psychiatry 2000;61:5-12(Suppl 1).
29. Delgado PL, Price LH, Miller HL, Salomon RM, Aghajanian GK, Heninger GR, Charney DS. Serotonin and the neurobiology of depression. Effects of tryptophan depletion in drug-free depressed patients. Arch Gen Psychiatry 1994;51:865-74.
30. McDougle CJ, Naylor ST, Cohen DJ, Aghajanian GK, Heninger GR, Price LH. Effects of tryptophan depletion in drug-free adults with autistic disorder. Arch Gen Psychiatry 1996;53:993-1000.
31. Smith KA, Fairburn CG, Cowen PJ. Symptomatic relapse in bulimia nervosa following acute tryptophan depletion. Arch Gen Psychiatry 1999;56:171-6.
32. Weltzin TE, Fernstrom MH, Fernstrom JD, Neuberger SK, Kaye WH. Acute tryptophan depletion and increased food intake and irritability in bulimia nervosa. Am J Psychiatry 1995;152:1668-71.
33. Kent JM, Coplan JD, Martinez J, Karmally W, Papp LA, Gorman JM. Ventilatory effects of tryptophan depletion in panic disorder: a preliminary report. Psychiatry Res 1996;64:83-90.
34. Goddard AW, Sholomskas DE, Walton KE, Augeri FM, Charney DS, Heninger GR, Goodman WK, Price LH. Effects of tryptophan depletion in panic disorder. Biol Psychiatry 1994;36:775-7.
35. Menkes DB, MacDonald JA. Interferons, serotonin and neurotoxicity. Psychol Med 2000;30:259-68.
36. Delgado PL, Moreno FA. Different roles for serotonin in anti-obsessional drug action and the pathophysiology of obsessive-compulsive disorder. Br J Psychiatry 1998;35:21-25(Suppl).
37. Young SN, Smith SE, Pihl R, Ervin FR. Tryptophan depletion causes a rapid lowering of mood in normal males. Psychopharmacology Berl 1985;87:173-7.
38. Leyton M, Young SN, Pihl RO, Etezadi S, Lauze C, Blier P, Baker GB, Benkelfat C. Effects on mood of acute phenylalanine/tyrosine depletion in healthy women. Neuropsychopharmacology 2000;22:52-63.
39. Winston F. Oral contraceptives and depression. Lancet 1969;1:1209.
40. Graham CA, Ramos R, Bancroft J, Maglaya C, Farley TM. The effects of steroidal contraceptives on the well-being and sexuality of women: a double-blind, placebo-controlled, two-centre study of combined and progestogen-only methods. Contraception 1995;52:363-369.
41. Baumblatt MJ, Winston F. Pyridoxine and the pill. Lancet 1970;1:832-3.
42. 6 requirements. Clin Sci 1972;42:465-77.
43. 6) upon depression associated with oral contraception. Lancet 1973;1:899-904.
44. 6 levels in depressed outpatients. Biol Psychiatry 1984;19:613-16.
45. 6 status. Contraception 1989;40:377-84.
46. Maes M, Claes M, Schotte C, Delbeke L, Jacquemyn Y, Verkerk R, Scharpe S. Disturbances in dexamethasone suppression test and lower availability of L-tryptophan and tyrosine in early puerperium and in women under contraceptive therapy. J Psychosom Res 1992;36:191-7.
47. Abou-Saleh MT, Ghubash R, Karim L, Krymski M, Anderson DN. The role of pterins and related factors in the biology of early postpartum depression. Eur Neuropsychopharmacol 1999;9:295-300.
48. Maes M, Ombelet W, Verkerk R, Bosmans E, Scharpe S. Effects of pregnancy and delivery on the availability of plasma tryptophan to the brain: relationships to delivery-induced immune activation and early post-partum anxiety and depression. Psychol Med 2001;31:847-58.
49. Kelly WF, Checkley SA, Bender DA. Cushing's syndrome, tryptophan and depression. Br J Psychiatry 1980;136:125-32.
50. Park S, Harrold JA, Widdowson PS, Williams G. Increased binding at 5-HT(1A), 5-HT(1B), and 5-HT(2A) receptors and 5-HT transporters in diet-induced obese rats. Brain Res 1999;847:90-7.
51. Cangiano C, Laviano A, Del Ben M, Preziosa I, Angelico F, Cascino A, Rossi FF. Effects of oral 5-hydroxy-tryptophan on energy intake and macronutrient selection in non-insulin dependent diabetic patients. Int J Obes Relat Metab Disord 1998;22:648-54.
52. Fierabracci V, Novelli M, Ciccarone AM, Masiello P, Benzi L, Navalesi R, Bergamini E. Effects of tryptophan load on amino acid metabolism in type 1 diabetic patients. Diabetes Metab 1996;22:51-6.
53. Hallert C, Sedvall G. Improvement in central monoamine metabolism in adult coeliac patients starting a gluten-free diet. Psychol Med 1983;13:267-71.
54. 6). Scand J Gastroenterol 1983;18:299-304.
55. Hernanz A, Polanco I. Plasma precursor amino acids of central nervous system monoamines in children with coeliac disease. Gut 1991;32:1478-81.
56. Beeken WL. Serum tryptophan in Crohn's disease. Scand J Gastroenterol 1976;11:735-40.
57. Lehmann J. Tryptophan deficiency stupor - a new psychiatric syndrome. Acta Psychiatr Scand Suppl 1982;300:1-57.
58. Trivedi S. Psychiatric symptoms in carcinoid syndrome. J Indian Med Assoc 1984;82:292-4.
59. Hanna SM. Carcinoid syndrome associated with psychosis. Postgrad Med J 1965;41:566-7.
60. Major LF, Brown GL, Wilson WP. Carcinoid and psychiatric symptoms. South Med J 1973;66:787-90.
61. Hashiro M, Okumura M. The relationship between the psychological and immunological state in patients with atopic dermatitis. J Dermatol Sci 1998;16:231-5.
62. Widner B, Sepp N, Kowald E, Kind S, Schmuth M, Fuchs D. Degradation of tryptophan in patients with systemic lupus erythematosus. Adv Exp Med Biol 1999;467:571-7.
63. Meyer KC, Arend RA, Kalayoglu MV, Rosenthal NS, Byrne GI, Brown RR. Tryptophan metabolism in chronic inflammatory lung disease. J Lab Clin Med 1995;126:530-40.
64. Fuchs D, Moller AA, Reibnegger G, Stockle E, Werner ER, Wachter H. Decreased serum tryptophan in patients with HIV-1 infection correlates with increased serum neopterin and with neurologic/psychiatric symptoms. J Acquir Immune Defic Syndr 1990;3:873-6.
65. Otsubo T, Miyaoka H, Kamijima K, Onuk M, Ishii M, Mitamura K. Depression during interferon therapy in chronic hepatitis C patients - a prospective study. Seishin Shinkeigaku Zasshi 1997;99:101-127.
66. Renault PF, Hoofnagle JH, Park Y, Mullen KD, Peters M, Jones DB, Rustgi V, Jones EA. Psychiatric complications of long-term interferon alfa therapy. Arch Intern Med 1987;147:1577-80.
67. Heeringa M, Honkoop P, de Man RA, Feenstra J, Smits CM. Major psychiatric side effects of interferon alpha-2b. Ned Tijdschr Geneeskd 1998;42:1618-21.
68. Janssen HL, Brouwer JT, van der Mast RC, Schalm SW. Suicide associated with alfa-interferon therapy for chronic viral hepatitis. J Hepatol 1994;21:241-3.
69. Niiranen A, Laaksonen R, Iivanainen M, Mattson K, Farkkila M, Cantell K. Behavioral assessment of patients treated with alpha-interferon. Acta Psychiatr Scand 1988;78:622-6.
70. Brown RR, Ozaki Y, Datta DP, Borden EC, Sondel PM, Malone DG. Implications of interferon-induced tryptophan catabolism in cancer, autoimmune diseases and AIDS. Adv Exp Med Biol 1991;294:425-35.
71. Schachter J, Brenner B, Fenig E, Yahav J, Marshak G, Sulkes A, Gutman H. Toxicity of adjuvant high-dose interferon-alpha-2b in patients with cutaneous melanoma at high risk of recurrence. Oncol Rep 1999;6:1389-93.
72. Poutiainen E, Hokkanen L, Niemi ML, Farkkila M. Reversible cognitive decline during high-dose alpha-interferon treatment. Pharmacol Biochem Behav 1994;47:901-5.
73. Pavol MA, Meyers CA, Rexer JL, Valentine AD, Mattis PJ, Talpaz M. Pattern of neurobehavioral deficits associated with interferon alfa therapy for leukemia. Neurology 1995;45:947-50.
74. Meyers CA, Scheibel RS, Forman AD. Persistent neurotoxicity of systemically administered interferon-alpha. Neurology 1991;41:672-6.
75. Musselman DL, Lawson DH, Gumnick JF, Manatunga AK, Penna S, Goodkin RS, Greiner K, Nemeroff CB, Miller AH. Paroxetine for the prevention of depression induced by high-dose interferon alpha. N Engl J Med 2001;344:961-6.
76. van Praag HM, Kahn RS, Asnis GM, Wetzler S, Brown SL, Bleich A, Korn ML. Denosologization of biological psychiatry or the specificity of 5-HT disturbances in psychiatric disorders. J Affect Disord 1987;13:1-8.
77. Reichenberg A, Yirmiya R, Schuld A, Kraus T, Haack M, Morag A, Pollmacher T. Cytokine-associated emotional and cognitive disturbances in humans. Arch Gen Psychiatry 2001;58:445-52.
78. Lucki I. The spectrum of behaviors influenced by serotonin. Biol Psychiatry 1998;44:51-162.
79. Jenkins C, Carmody TJ, Rush AJ. Depression in radiation oncology patients: a preliminary evaluation. J Affect Disord 1998;50:17-21.
80. Strite D, Valentine AD, Meyers CA. Manic episodes in two patients treated with interferon alpha. J Neuropsychiatry Clin Neurosci 1997;9:273-6.
81. Iancu I, Sverdlik A, Dannon PN, Lepkifker E. Bipolar disorder associated with interferon-alpha treatment. Postgrad Med J 1997;73:834-5.
82. Nozaki O, Takagi C, Takaoka K, Takata T, Yoshida M. Psychiatric manifestations accompanying interferon therapy for patients with chronic hepatitis C: an overview of cases in Japan. Psychiatry Clin Neurosci 1997;51:175-80.